CD4 and neoplasm: These data demonstrate that high-dose Lipo-MP-LPS can induce both an early recruitment of CD4+ T helpers at the tumor site and the polarization of TAM toward an M1 phenotype, which could help enhance a pre-existing antitumor immune response.